Stemtech (STEK) Stock Price

Stemtech Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Stemtech has contracted by 13.0% per year over the past 6 years to 2.88 M USD. Stemtech's net margin stands at -140.7%, up from -353.7% several years earlier.

Stemtech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech business model & stock analysis

Stemtech Corp. engages in the development of nutritional supplements. The company is headquartered in Naples Florida, Florida and currently employs 45 full-time employees. The company went IPO on 2014-09-15. The firm is also known as Stem Cell Nutrition Company. The firm's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The firm markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). The company also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.

Frequently asked questions about Stemtech

Converted at the current exchange rate, the Stemtech share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Stemtech.

The profit cannot currently be calculated for Stemtech.

The P/E ratio cannot be calculated for Stemtech at the moment.

The P/S cannot be calculated for Stemtech currently.

The Eulerpool Quality Score for Stemtech is 2/10.

The ISIN of Stemtech is US85859W1027. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Stemtech is STEK. The ticker symbol is used to trade Stemtech shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
63,919.56 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website stemtech.com
Currency
USD
Initial public offering
Sep 15, 2014
ISIN
US85859W1027
Cusip
85859W102
Market capitalization
23,198.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
58.15 %
Last updated Oct 28, 2026, 11:00 AM

Stemtech Peer Group

Stemtech Ticker

OTC · STEK

Stemtech FIGI

STEK:US · BBG001ZZV5C2STEK:PQ · BBG001ZZV5S5STEK:UV · BBG001ZZV5V1

All fundamentals and in-depth analysis of Stemtech

Our stock analysis for Stemtech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stemtech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.